Blunted hormone responses to ipsapirone are associated with trait impulsivity in personality disorder patients

Neuropsychopharmacology

Volumn 31, Issue 1, 2006, Pages 197-203

  Minzenberg, Michael J ^a,b,e   Grossman, Robert ^a   New, Antonia S ^a,b   Mitropoulou, Vivian ^a   Yehuda, Rachel ^a,b   Goodman, Marianne ^a,b   Reynolds, Diedre A ^c   Silverman, Jeremy M ^a   Coccaro, Emil F ^d   Marcus, Sue ^a   Siever, Larry J ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Department of Psychiatry   (United States)

^c BAYSTATE MEDICAL CENTER   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

5 HT1A; Borderline personality disorder; Cortisol; Impulsivity; Prolactin; Receptor; Serotonin

Indexed keywords

AUTORECEPTOR; DOPAMINE 2 RECEPTOR; HYDROCORTISONE; IPSAPIRONE; PROLACTIN; SEROTONIN; SEROTONIN 1A RECEPTOR;

ADULT; AGGRESSION; ANXIETY; ARTICLE; BORDERLINE STATE; CHILD ABUSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HORMONE RESPONSE; HOSTILITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHESIS; IMPULSIVENESS; INTERMITTENT EXPLOSIVE DISORDER; MAJOR CLINICAL STUDY; MALE; PERSONALITY DISORDER; POST HOC ANALYSIS; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN FUNCTION; SELF REPORT; SEROTONINERGIC SYSTEM; STEP WISE MULTIPLE REGRESSION; TEMPERATURE MEASUREMENT;

ADULT; BODY TEMPERATURE; FEMALE; HORMONES; HUMANS; HYDROCORTISONE; IMPULSIVE BEHAVIOR; MALE; PERSONALITY DISORDERS; PROLACTIN; PSYCHIATRIC STATUS RATING SCALES; PYRIMIDINES; SEROTONIN AGONISTS;

EID: 32844454867     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300853     Document Type: Article

References (47)

1. Battle CL, Shea MT, Johnson DM, Yen S, Zlotnick C, Zanarini MC et al (2004). Childhood maltreatment associated with adult personality disorders: findings from the Collaborative Longitudinal Personality Disorders Study. J Pers Disord 18: 193-211.
2. 1A receptor influences on rodent social and agonistic behavior: a review and empirical study. Neurosci Biobehav Rev 18: 325-338.
3. Bernstein DP, Fink L (1998). Childhood Trauma Questionnaire: A Retrospective Self-Report Manual. Psychological Corporation: San Antonio, TX.
4. Brett PM, Curtis D, Robertson MM, Gurling HM (1995). Exclusion of the 5-HT1A serotonin neuroreceptor and tryptophan oxygenase genes in a large British kindred multiply affected with Tourette's syndrome, chronic motor tics, and obsessive-compulsive behavior. Am J Psychiatry 152: 437-440.
5. Buss AH, Durkee A (1957). An inventory for assessing different kinds of hostility. J Consult Psychol 21: 343-349.
6. 1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study. Int Clin Psychopharmacol 13: 23-32.
7. 1A receptor function and aggression. Psychopharmacology 148: 344-349.
8. 1A receptors in impulsive aggressive behavior in humans. Psychopharmacol Bull 26: 393-405.
9. Coccaro EF, Kavoussi RJ, Hauger RL (1995). Physiological responses to d-fenfluramine and ipapirone challenge correlate with indices of aggression in males with personality disorder. Int Clin Psychopharmacol 10: 177-179.
10. Coccaro EF, Kavoussi RJ, Berman ME, Lish JD (1998). Intermittent explosive disorder-revised: development, reliability, and validity of research criteria. Compr Psychiatry 39: 368-376.
11. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H et al (2000). Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clin Genet 57: 178-196.
12. Cowen PJ, Anderson IA, Grahame-Smith DG (1990). Neuroendocrine effects of azapirones. J Clin Psychopharmacol 10: 21S-25S.
13. De Vry J (1995). 5-HT1A receptor agonists: recent developments and controversial issues. Psychopharmacology (Berl) 121: 1-26.
14. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ et al (1999). PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46: 1375-1387.
15. Ekstrom D, Quade D, Golden RN (1990). Statistical analysis of repeated measures in psychiatric research. Arch Gen Psychiatry 47: 770-772.
16. First MB, Spitzer RL, Gibbon M, Williams JBW, Benjamin LS (1995). User's Guide for the Structured Clinical Interview for DSM-IV Axis I (SCID-I). American Psychiatric Press: Washington, DC.
17. Fuller R (1992). The involvement of serotonin in regulation of pituitary-adrenocortical function. Front Neuroendocrinol 13: 250-270.
18. Gatch MB (2003). Discriminative stimulus effects of m- chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety. Life Sci 73: 1347-1367.
19. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
20. 1A dysfunction in borderline personality disorder. Psychol Med 32: 935-941.
21. Heim C, Nemeroff CB (2001). The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 49: 1023-1039.
22. Hennen J (2003). Statistical methods for longitudinal research on bipolar disorders. Bipolar Disord 5: 156-168.
23. Hollander E, Stein DJ, DeCaria CM, Cohen L, Saoud JB, Skodol AE et al (1994). Serotonergic sensitivity in borderline personality disorder: preliminary findings. Am J Psychiatry 151: 277-280.
24. Kahn RS, Trestman R, Lawlor BA, Gabriel S, Davidson M, Siever L (1994). Effects of ipsapirone in healthy subjects: a dose-response study. Psychopharmacology 114: 155-160.
25. Klaasen T, Riedel WJ, van Praag HM, Menheere PPCA, Griez E (2002). Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression. Psychiatry Res 113: 29-40.
26. Koenigsberg HW, Teicher MH, Mitropoulou V, Navalta C, New AS, Trestman R et al (2004). 24-h monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. J Psychiatr Res 38: 503-511.
27. Kristensen M, Hansen T (2004). Statistical analyses of repeated measures in physiological research: a tutorial. Adv Physiol Educ 28: 2-14.
28. Lam S, Shen Y, Nguyen T, Messier TL, Brann M, Comings D et al (1996). A serotonin receptor gene (5HT1A) variant found in a Tourette's syndrome patient. Biochem Biophys Res Commun 219: 853-858.
29. Lee R, Coccaro E (2001). The neuropsychopharmacology of criminality and aggression. Can J Psychiatry 46: 35-44.
30. Lesch KP, Rupprecht R, Poten B, Muller U, Sohnle K, Fritze J et al (1989). Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans. Biol Psychiatry 26: 203-205.
31. 1A) receptor activation: effects of 5-HT receptor and β-adrenoceptor antagonists. J Clin Endocrinol Metab 70: 670-674.
32. 1A receptor responsivity in anxiety disorders and depression. Prog Neuro-Psychopharmacol Biol Psychiatry 15: 723-733.
33. Lieb K, Rexhausen JE, Kahl KG, Schweiger U, Philipsen A, Hellhammer DH et al (2004). Increased diurnal salivary cortisol in women with borderline personality disorder. J Psychiatr Res 38: 559-565.
34. Meltzer HY, Gudelsky GA, Lowy MT, Nash JF, Koenig JI (1991). Neuroendocrine effects of buspirone: mediation by dopaminergic and serotonergic mechanisms. In: Tunnicliff G, Eison AS, Taylor OP (eds). Buspirone: Mechanisms and Clinical Aspects. Academic Press: San Diego. pp 177-192.
35. Meltzer HY, Maes M (1995). Effects of ipsapirone on plasma cortisol and body temperature in major depression. Biol Psychiatry 38: 450-457.
36. Minzenberg MJ, Siever LJ (2005). Biochemical Endophenotypes in Borderline Personality Disorder. In: Zanarini MC (ed). Borderline Personality Disorder. Dekker: New York.
37. Moeller FG, Allen T, Cherek DR, Dougherty DM, Lane S, Swann AC (1998). Ipsapirone neuroendocrine challenge: relationship to aggression as measured in the human laboratory. Psychiatry Res 81: 31-38.
38. Netter P, Hennig J, Roed IS (1996). Serotonin and dopamine as mediators of sensation seeking behavior. Neuropsychobiology 34: 155-165.
39. Netter P, Hennig J, Rohrmann S (1999). Psychobiological differences between the aggression and psychoticism dimension. Pharmacopsychiatry 32: 5-12.
40. New AS, Hazlett EA, Buchsbaum MS, Goodman M, Reynolds D, Mitropoulou V et al (2002). Blunted prefrontal cortical ISfluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry 59: 621-629.
41. Olivier B, Mos J, van Oorschot R, Hen R (1995). Serotonin receptors and animal models of aggressive behavior. Pharmacopsychiatry 28S: 80-90.
42. Patton JH, Stanford MS, Barratt ES (1995). Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51: 768-774.
43. Pfohl BM, Blum N, Zimmerman M, Stangl D (1989). Structured Interview for DSM-III-R Personality: SIDP-R. Author: Iowa City, IA.
44. 18F] flurodeoxyglucose positron emission tomomgraphy. Neuropsychopharmacology 20: 413-423.
45. Soloff PH, Meltzer CC, Greer PJ, Constantine D, Kelly TM (2000). A fenfluramine-activated FDG-PET study of borderline personality disorder. Biol Psychiatry 47: 540-547.
46. Spielberger CD, Gorsuch RC, Lushene RE, Vagg PR, Jacobs GA (1983). Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press: Palo Alto, CA.
47. Yatham LN, Shiah IS, Lam RW, Tam EM, Zis AP (1999). Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls. J Affect Disord 54: 295-301.